Adamas Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Adamas Pharmaceuticals (ADMS) Tops Q4 EPS by 5c
May 13, 2015 4:01 PM EDTAdamas Pharmaceuticals (NASDAQ: ADMS) reported Q4 EPS of ($0.69), $0.05 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Adamas Pharmaceuticals (ADMS) click here.
... More